Announce Date | 03/28/2025 |
EPS Normalized Actual | $-2.7 (Beat by $0.05) |
EPS GAAP Actual | $-2.7 (Beat by $0.05) |
Revenue Actual | $0.023996B |
Revenue Surprise | Beat by $23.996M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.17 |
EPS GAAP Estimate | $-0.17 |
Revenue Estimate | $0.046883B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | -0.24 | -6.25 | -0.24723 | -0.23162 | 1 |
Dec 2025 | -0.455 | -3.3 | -0.94 | 0.03 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -14.18 | -14.26 | 0.023996B | -61.74% | -30.16M |
FQ3 2024 (Sep 2024) | -0.41 | -0.04333 | 0.03629B | -36.86% | -7.4M |
FQ2 2024 (Jun 2024) | -0.15 | -1.49259 | 0.038514B | -22.17% | -55.59M |
FQ1 2024 (Mar 2024) | -0.76 | -0.76 | 0.037093B | -11.04% | 37.09M |
FQ4 2023 (Dec 2023) | -1.82 | -1.82 | 0.038812B | -10.31% | 38.81M |
FQ3 2023 (Sep 2023) | -1.9 | -1.9 | 0.049667B | -38.39% | 49.67M |
FQ2 2023 (Jun 2023) | -0.0864 | -0.0864 | 0.047052B | -26.73% | 47.05M |
FQ1 2023 (Mar 2023) | -0.039 | -0.039 | 0.041189B | 100% | 41.19M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.17
Consensus Revenue Estimates
0.046883B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 0 |
FQ1 2026 (Mar 2026) | 0 | -- | 0 | 0 | 0 |
FQ4 2025 (Oct 2025) | 0.05 | 28460 | 0.04900521 | 0.05059687 | 1 |
FQ3 2025 (Jul 2025) | -0.17 | -141.18 | -0.17203 | -0.16662 | 1 |
FQ2 2025 (Jun 2025) | -0.17 | 11.76 | -0.17568 | -0.16628 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.04B | 1 |
FQ3 2026 (Sep 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ2 2026 (Jun 2026) | 0.04B | -- | 0.03B | 0.04B | 1 |
FQ1 2026 (Mar 2026) | 0.03B | -- | 0.03B | 0.04B | 1 |
FQ4 2025 (Oct 2025) | 0.05B | 55.75 | 0.05B | 0.05B | 0 |
FQ3 2025 (Jul 2025) | 0.05B | 22.59 | 0.05B | 0.05B | 0 |
FQ2 2025 (Jun 2025) | 0.05B | 17.85 | 0.05B | 0.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.08 | -14.18 | -14.26 | 100.56% |
FQ3 2024 (Sep 2024) | -0.36667 | -0.41 | -0.04333 | 10.57% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.15 | -1.49259 | 995.06% |
FQ1 2024 (Mar 2024) | -0.76 | -0.76 | 100% | |
FQ4 2023 (Dec 2023) | -1.82 | -1.82 | 100% | |
FQ3 2023 (Sep 2023) | -1.9 | -1.9 | 100% | |
FQ2 2023 (Jun 2023) | -0.0864 | -0.0864 | 100% | |
FQ1 2023 (Mar 2023) | -0.039 | -0.039 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.05B | $0.02B | $-30.16M | -125.7% |
FQ3 2024 (Sep 2024) | $0.04B | $0.04B | $-7.4M | -20.4% |
FQ2 2024 (Jun 2024) | $0.09B | $0.04B | $-55.59M | -144.34% |
FQ1 2024 (Mar 2024) | $0B | $0.04B | $37.09M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.04B | $38.81M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.05B | $49.67M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.05B | $47.05M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.04B | $41.19M | 100% |